X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (141) 141
Publication (16) 16
Book Chapter (7) 7
Book Review (4) 4
Conference Proceeding (3) 3
Dissertation (2) 2
Data Set (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nrtis (104) 104
humans (77) 77
index medicus (55) 55
pharmacology & pharmacy (48) 48
hiv infections - drug therapy (47) 47
hiv (39) 39
infectious diseases (36) 36
antiretroviral therapy (30) 30
anti-hiv agents - pharmacology (29) 29
nnrtis (26) 26
hiv-1 - drug effects (25) 25
male (24) 24
female (23) 23
anti-hiv agents - therapeutic use (22) 22
hiv infections - virology (22) 22
nucleoside reverse transcriptase inhibitors (22) 22
reverse transcriptase inhibitors - therapeutic use (22) 22
zidovudine (22) 22
antiviral agents (21) 21
protease inhibitors (21) 21
adult (20) 20
aids (20) 20
human-immunodeficiency-virus (20) 20
reverse transcriptase inhibitors - pharmacology (20) 20
mitochondrial toxicity (19) 19
animals (18) 18
microbiology (18) 18
mutation (17) 17
reverse-transcriptase inhibitors (17) 17
tenofovir (17) 17
haart (16) 16
virology (16) 16
drug resistance (15) 15
anti-hiv agents - adverse effects (14) 14
biochemistry & molecular biology (14) 14
drug therapy, combination (14) 14
hiv-1 - genetics (14) 14
middle aged (14) 14
active antiretroviral therapy (13) 13
article (13) 13
drug resistance, viral (13) 13
highly active antiretroviral therapy (13) 13
lamivudine (13) 13
resistance (13) 13
stavudine (13) 13
virus diseases (13) 13
hiv infection (12) 12
immunology (12) 12
reverse transcriptase inhibitors (12) 12
antiretroviral drugs (11) 11
drug-resistance (11) 11
hiv reverse transcriptase - genetics (11) 11
nucleoside (11) 11
nucleosides (11) 11
reverse transcriptase (11) 11
reverse transcriptase inhibitors - adverse effects (11) 11
abacavir (10) 10
dna polymerases (10) 10
hiv reverse transcriptase - antagonists & inhibitors (10) 10
hiv/aids (10) 10
immunodeficiency-virus type-1 (10) 10
pis (10) 10
research (10) 10
adenine - analogs & derivatives (9) 9
anti-hiv agents - administration & dosage (9) 9
dna (9) 9
drugs (9) 9
hiv-1 (9) 9
human immunodeficiency virus--hiv (9) 9
inhibitors (9) 9
reverse transcriptase inhibitors - administration & dosage (9) 9
treatment outcome (9) 9
antiretroviral therapy, highly active (8) 8
drug resistance, viral - genetics (8) 8
efficacy (8) 8
genotype (8) 8
hiv-1-infected patients (8) 8
hiv-infected patients (8) 8
in-vitro (8) 8
mitochondria - drug effects (8) 8
non-nucleoside reverse transcriptase inhibitors (8) 8
pharmacokinetics (8) 8
reverse transcriptase inhibitors - chemistry (8) 8
rna-directed dna polymerase (8) 8
viral load (8) 8
analysis (7) 7
azt (7) 7
didanosine (7) 7
drug therapy (7) 7
health aspects (7) 7
hiv reverse transcriptase - metabolism (7) 7
human immunodeficiency virus (7) 7
kinetics (7) 7
mitochondrial dna (7) 7
mutations (7) 7
oxidative stress (7) 7
stavudine - pharmacology (7) 7
toxicity (7) 7
toxicology (7) 7
adenine - pharmacology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 08/2016, Volume 113, Issue 33, pp. 9274 - 9279
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 09/2019, Volume 74, Issue 9, pp. 2716 - 2722
Abstract Objectives In a context of life-long therapy, we asked whether it could be possible to reduce the number of antiretroviral drugs without jeopardizing... 
INFECTIOUS DISEASES | PLUS LAMIVUDINE | EFFICACY | RALTEGRAVIR | SAFETY | MICROBIOLOGY | HIV-1-INFECTED PATIENTS | OPEN-LABEL | VIROLOGICAL SUPPRESSION | NON-INFERIORITY | DUAL THERAPY | INACTIVE NRTIS | PHARMACOLOGY & PHARMACY
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 06/2019, Volume 852, pp. 159 - 166
Nucleoside reverse transcriptase inhibitors (NRTIs) form the backbone in combination antiretroviral therapy (cARVs). They halt chain elongation of the viral... 
Mitochondria | Naringenin | NRTIs | DNA polymerase | OXIDATIVE STRESS | ANALOGS | DEOXYNUCLEOTIDES | MECHANISMS | PROTEASE INHIBITORS | HIV | ACTIVE ANTIRETROVIRAL THERAPY | DRUGS | PHARMACOLOGY & PHARMACY | INFECTED PATIENTS | LACTIC-ACIDOSIS
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 4/2017, Volume 73, Issue 4, pp. 463 - 468
Journal Article
Journal Article
International Journal of Surgery Case Reports, ISSN 2210-2612, 2019, Volume 61, pp. 64 - 66
The authors present a case of multinodular goiter in an HIV-positive patient affected by lipodystrophy with particular accumulation of adipose tissue in the... 
Lipodystrophy | Thyroidectomy | Highly active anti-retroviral therapy (HAART) | HIV positive
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 3, pp. 3895 - 3907
Low fertility is one of the most common side effects caused by nucleoside reverse transcriptase inhibitors (NRTIs), whereas the molecular mechanism underlying... 
Low fertility | NRTIs | Mitochondrial toxicity | Autophagy | APOPTOSIS | autophagy | FERTILIZATION | low fertility | MOUSE | GUIDELINES | TOXICITY | MITOCHONDRIAL-DNA | MATURATION | CELL BIOLOGY | PATHWAY | mitochondrial toxicity | MOTILITY | LIFE
Journal Article
Journal of clinical pharmacology, ISSN 0091-2700, 9/2009, Volume 49, Issue 9, pp. 1079 - 1090
There are limited data on the pharmacokinetics of generic nucleoside reverse transcriptase inhibitors (NRTIs) in native African populations, where they are... 
pharmacokinetics | NRTIs | rifampin | interindividual variability | UGT2B7
Journal Article
03/2008
Objectives: To investigate the gastrointestinal tract (GIT) permeability of five nucleoside analogue reverse transcriptase inhibitors (NRTIs), viz.,... 
Rifampicin | solubility | degradation | NRTIs | gastrointestinal permeability
Web Resource
Journal of Pharmacological Sciences, ISSN 1347-8613, 04/2019, Volume 139, Issue 4, pp. 275 - 279
This study aims to investigate the prevalence and types of drug resistance mutations among patients failing first-line antiretroviral therapy (ART). Plasma... 
HIV-1 | Drug resistance mutations | NRTIs | First-line ART | Drug resistance rate | NNRTIs | SUBTYPE | POPULATION | GENE | PHARMACOLOGY & PHARMACY | TRANSCRIPTASE INHIBITOR RESISTANCE | PREVALENCE | Antiviral agents | Analysis | Dosage and administration | Research | Drug resistance | HIV (Viruses) | Drug therapy | Prevalence studies (Epidemiology)
Journal Article